Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why enGene Therapeutics (NASDAQ:ENGN) Is Drawing Attention Amid Bladder Cancer Industry Developments

● Cash and securities were $285.2 million at April 30, after a roughly 50% workforce reduction.

Nitish Kishor | 12 October 2026

Why Evolent Health (NYSE:EVH) Regulatory Developments Are Worth Watching on Monday

● Second-quarterRevenuerose to $652.5 million from $444.3 million, driven by the company's Performance Suite.

Nitish Kishor | 12 October 2026

Why Did Hims & Hers Health (NYSE:HIMS) Gain in a Firmer Healthcare Tape?

● HIMS closed Friday, October 9, 2026, at $30.92, up 10.19%, among the session’s stronger performers.

Nitish Kishor | 12 October 2026

Humana (NYSE:HUM) in Focus After CMS Restores Its Four-Star Medicare Advantage Rating

● CMS restored Humana’s flagshipMedicareAdvantage contract to a four-star rating, up from the 3.5-star level it had carried.

Nitish Kishor | 12 October 2026

Iovance Biotherapeutics (NASDAQ:IOVA) Stock: Cell-Therapy Name Joins the Healthcare Rebound

● IOVA closed Friday, October 9, 2026, at $14.62, up 9.84%, among the session’s stronger performers.

Nitish Kishor | 12 October 2026

Arcutis Biotherapeutics (NASDAQ:ARQT) Stock: Healthcare Leads the Market Higher

● ARQT closed Friday, October 9, 2026, at $26.58, up 8.53%, among the stronger US gainers of the session.

Nitish Kishor | 12 October 2026

Why Did Brookdale Senior Living (NYSE:BKD) Slip Without a Clear Catalyst?

● BKD closed Friday, October 9, 2026, at $10.12, down 7.07%, among the session’s decliners as the market rose.

Nitish Kishor | 12 October 2026

Bolt Biotherapeutics (NASDAQ:BOLT) Stock: Small-Cap Biotech Meets a Supportive Healthcare Tape

● BOLT closed Friday, October 9, 2026, at $4.340, up 18.90%, among the notable small-cap biotechnology gainers.

Nitish Kishor | 12 October 2026

Why Is Caris Life Sciences (NASDAQ:CAI) Moving Amid Broad Healthcare Strength?

● CAI closed Friday, October 9, 2026, at $29.70, up 8.00%, among the stronger US gainers of the session.

Nitish Kishor | 12 October 2026

Concord Medical Services (NYSE:CCM) Climbs on ADR Momentum

● CCM closed Friday, October 9, 2026, at $3.620, up 16.77%, among the firmer small-cap American depositary receipts.

Nitish Kishor | 12 October 2026
Support

Hi! How can we help you today?

Loading…